Loading organizations...
Moon Surgical develops robotic systems designed to enhance soft tissue procedures. Its core offering, the Maestro system, augments human surgical capabilities, providing precision and assistance directly to surgeons. The company integrates advanced robotics into operating rooms, making complex surgeries more efficient and accessible for professionals across various specialties.
Initially known as MastOR, the company was founded in Paris by Professor Brice Gayet. Anne Osdoit subsequently joined as CEO, providing executive leadership. Moon Surgical secured its foundational seed investment in June 2020, formally launching its mission within surgical robotics. The initial vision focused on overcoming surgical limitations through technological advancement.
Moon Surgical's technology targets surgeons performing diverse soft tissue operations, seeking improved patient outcomes and streamlined workflows. The company envisions robotic assistance as a future standard in high-volume surgical practices globally, elevating surgery. Its long-term mission is to inspire continuous innovation and make a significant, positive impact on worldwide patient care.
Moon Surgical has raised $94.0M across 4 funding rounds.
Moon Surgical has raised $94.0M in total across 4 funding rounds.
Moon Surgical is a technology company specializing in advanced robotic systems for laparoscopic surgery. Its flagship product, the Maestro™ System, is designed to assist surgeons in performing minimally invasive soft tissue procedures with enhanced precision, control, and efficiency. The system serves surgeons, operating room staff, and patients by addressing a large market of approximately 18.8 million annual soft tissue surgeries not currently covered by existing robotic platforms. It integrates seamlessly into existing clinical workflows, improving operating room efficiency, reducing procedure times, and enabling alternative labor models. Moon Surgical has demonstrated growth momentum with successful European pilot programs and recent FDA clearance for commercial use in the United States, positioning it for broader adoption in general, bariatric, and gynecologic surgeries[1][2][3].
Founded in 2020, Moon Surgical is headquartered in Paris, France, and San Francisco, California. The company was established with the vision of revolutionizing laparoscopic surgery through robotics and data-driven insights. Anne Osdoit, CEO of Moon Surgical and a partner at Sofinnova Partners' medtech accelerator, MD Start, leads the company. The idea emerged from the need to enhance surgeon capabilities in minimally invasive procedures by providing stable visualization, reliable retraction, and total control. Early traction included CE marking in September 2023 and treatment of over 200 patients across multiple surgical specialties in Europe, which validated the system’s clinical utility and paved the way for FDA clearance and U.S. market entry[1][2].
Moon Surgical is riding the wave of digital transformation and robotics in healthcare, particularly in minimally invasive surgery. The timing is favorable due to increasing demand for laparoscopic procedures driven by aging populations and rising obesity rates, especially in bariatrics—a market growing at a 9% CAGR globally. The company’s focus on soft tissue surgeries fills a significant gap left by existing robotic systems that primarily target other surgical areas. By integrating AI and data analytics into the operating room, Moon Surgical is contributing to the broader trend of smart, connected healthcare environments that improve patient outcomes and operational efficiency[1][2][4].
Moon Surgical is poised for rapid growth as it expands commercial programs in the U.S. following FDA clearance and continues to scale its presence in Europe. Future trends shaping its journey include the increasing adoption of AI in surgery, demand for cost-effective robotic solutions, and the digitalization of operating rooms. As the Maestro System evolves with enhanced digital capabilities and data-driven insights, Moon Surgical’s influence is likely to grow, potentially setting new standards for collaborative robotic surgery and transforming surgical care delivery worldwide[1][4].
Moon Surgical has raised $94.0M across 4 funding rounds. Most recently, it raised $55.0M Series B in May 2023.
Moon Surgical has raised $94.0M in total across 4 funding rounds.
Moon Surgical's investors include Soffinova Partners, Mohamed (Sid) Siddeek, 99 Startups, Ascension Ventures, Cathay Health, Endeavor Venture Funds, Gradient Ventures, Nazca Ventures, New Enterprise Associates (NEA), Jenny Johnston, Sonder Capital, Colin Cahill.